INFLIXIMAB

INFLIXIMAB (13778E)

infliximab 100 mg injection, 1 vial
13778E
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required

Restriction

Indication: Ankylosing spondylitis
Treatment phase: Initial treatment - Initial 1 (new patient)

Restriction

Indication: Ankylosing spondylitis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)

Restriction

Indication: Ankylosing spondylitis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $202.49 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Inflectra
Ixifi
Remsima
Renflexis